http://orcid.org/0000-0002-5832-1822
Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Elmira Karami, Maryam Mesbahi Moghaddam, Mahdi Behdani & Fatemeh Kazemi-Lomedasht. (2023) Effective blocking of neuropilin-1activity using oligoclonal nanobodies targeting different epitopes. Preparative Biochemistry & Biotechnology 53:5, pages 523-531.
Read now
Read now
Ayda Hassanzadeh Eskafi, Akbar Oghalaei, Fereidoun Mahboudi, Hajarsadat Ghaderi, Mahdi Behdani, Alireza Shoari & Fatemeh Kazemi-Lomedasht. (2023) Investigation of the therapeutic potential of recombinant bispecific bivalent anti-PD-L1/VEGF nanobody in inhibition of angiogenesis. Immunopharmacology and Immunotoxicology 45:2, pages 197-202.
Read now
Read now
Shuyang Sun, Ziqiang Ding, Xiaomei Yang, Xinyue Zhao, Minlong Zhao, Li Gao, Qu Chen, Shenxia Xie, Aiqun Liu, Shihua Yin, Zhiping Xu & Xiaoling Lu. (2021) Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy. International Journal of Nanomedicine 16, pages 2337-2356.
Read now
Read now
Shamsi Naderi, Reyhaneh Roshan, Mahdi Behdani & Fatemeh Kazemi-Lomedasht. (2021) Inhibition of neovascularisation in human endothelial cells using anti NRP-1 nanobody fused to truncated form of diphtheria toxin as a novel immunotoxin. Immunopharmacology and Immunotoxicology 43:2, pages 230-238.
Read now
Read now
Farnaz Khodabakhsh, Serge Muyldermans, Mahdi Behdani & Fatemeh Kazemi-Lomedasht. (2020) Liposomal delivery of vascular endothelial growth factor/receptors and their inhibitors. Journal of Drug Targeting 28:4, pages 379-385.
Read now
Read now
Elmira Karami, Jean-Marc Sabatier, Mahdi Behdani, Shiva Irani & Fatemeh Kazemi-Lomedasht. (2020) A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 1233-1239.
Read now
Read now
Himanshu Kumar. (2018) Faces of antibody in immunopathology and immunotherapy. International Reviews of Immunology 37:6, pages 277-278.
Read now
Read now
Articles from other publishers (60)
Yuting Zhang, Dan Wang, Qi Xiang, Xiaohui Hu, Yuting Zhang, Lijie Wu, Zhaoyong Zhang, Yanqun Wang, Jincun Zhao, Peter J. McCormick, Jinheng Fu, Yang Fu, Jin Zhang, Haihai Jiang & Jian Li. (2024) A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein. Virology 589, pages 109925.
Crossref
Crossref
Zongqing Huang, Haoju Hua, Xiuzhen Du, Zipeng Zhen, Wei Zhao, Jun Feng & Ji-an Li. (2024) A specific nanobody-based affinity chromatography resin as a platform for small ubiquitin-related modifier fusion protein purification. Journal of Chromatography A 1713, pages 464508.
Crossref
Crossref
Miao Xie, Qiushuang Zhang, Yuanyuan Guo, Lijuan Zhu, Xinyuan Zhu & Chuan Zhang. (2023) EGFR-targeted and gemcitabine-incorporated chemogene for combinatorial pancreatic cancer treatment. Nano Research.
Crossref
Crossref
Claudio Rodríguez-Camejo, Triana Delfin-Riela, Martín A. Rossotti, Arturo Puyol, César Echaides, Ana Hernández & Gualberto González-Sapienza. (2023) A highly sensitive nanobody-based ELISA for bovine β-lactoglobulin to classified donated human milk destined to susceptible newborns. Food Control 153, pages 109910.
Crossref
Crossref
Yoshiya Tanaka, Masafumi Kawanishi, Megumi Nakanishi, Hironori Yamasaki & Tsutomu Takeuchi. (2023) Efficacy and safety of anti-TNF multivalent NANOBODY® compound ‘ozoralizumab’ without methotrexate co-administration in patients with active rheumatoid arthritis: A 52-week result of phase III, randomised, open-label trial (NATSUZORA trial). Modern Rheumatology 33:5, pages 875-882.
Crossref
Crossref
Yoshiya Tanaka, Masafumi Kawanishi, Megumi Nakanishi, Hironori Yamasaki & Tsutomu Takeuchi. (2023) Efficacy and safety of the anti-TNF multivalent NANOBODY® compound ozoralizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: A 52-week result of a Phase II/III study (OHZORA trial). Modern Rheumatology 33:5, pages 883-890.
Crossref
Crossref
Michelle Koerselman, Lisanne C.M. Morshuis & Marcel Karperien. (2023) The use of peptides, aptamers, and variable domains of heavy chain only antibodies in tissue engineering and regenerative medicine. Acta Biomaterialia.
Crossref
Crossref
C. P. Ortega, L. M. Rivera & L. E. Trujillo. (2023) Production of nanobodies in Andean camelids and their most common applications: A general review in the medical field.. Bionatura 8:2, pages 1-12.
Crossref
Crossref
Lorena-Andreea Bocancia-Mateescu, Dana Stan, Andreea-Cristina Mirica, Miruna Gabriela Ghita, Diana Stan & Lavinia Liliana Ruta. (2023) Nanobodies as Diagnostic and Therapeutic Tools for Cardiovascular Diseases (CVDs). Pharmaceuticals 16:6, pages 863.
Crossref
Crossref
Chen Liu, Ling-Xiao Liu, Jie Yang & Yun-Guo Liu. (2023) Exploration and analysis of the composition and mechanism of efficacy of camel milk. Food Bioscience 53, pages 102564.
Crossref
Crossref
Sunanda Singh, Samara P. Singh & Ashutosh S. Parihar. (2023) Application of Nano-Antibodies for Cancer Immunotherapy. Current Tissue Microenvironment Reports 4:2, pages 17-27.
Crossref
Crossref
Bo-kyung Jin, Steven Odongo, Magdalena Radwanska & Stefan Magez. (2023) Nanobodies: A Review of Generation, Diagnostics and Therapeutics. International Journal of Molecular Sciences 24:6, pages 5994.
Crossref
Crossref
Joel Yong, Albert S. Mellick, John Whitelock, Joseph Wang & Kang Liang. (2023) A Biomolecular Toolbox for Precision Nanomotors. Advanced Materials, pages 2205746.
Crossref
Crossref
Yajun Zhou, Xing Lu, Xiaoqing Wang, Tianlei Ying & Xiangshi Tan. (2023) Potent Therapeutic Strategies for COVID-19 with Single-Domain Antibody Immunoliposomes Neutralizing SARS-CoV-2 and Lip/cGAMP Enhancing Protective Immunity. International Journal of Molecular Sciences 24:4, pages 4068.
Crossref
Crossref
Alja Zottel, Metka Novak, Neja Šamec, Bernarda Majc, Sara Colja, Mojca Katrašnik, Miloš Vittori, Barbara Hrastar, Ana Rotter, Andrej Porčnik, Tamara Lah Turnšek, Radovan Komel, Barbara Breznik & Ivana Jovčevska. (2023) Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo. Cancers 15:3, pages 573.
Crossref
Crossref
Alia Nur, Maren Schubert, Jing Yi Lai, Michael Hust, Yee Siew Choong, Wan Yus Haniff Wan Isa & Theam Soon Lim. 2023. Phage Display. Phage Display
3
12
.
Fangqi Jing, Xiaowei Liu, Xiaoxuan Chen, Fanglong Wu & Qinghong Gao. (2022) Tailoring biomaterials and applications targeting tumor-associated macrophages in cancers. Frontiers in Immunology 13.
Crossref
Crossref
Tsutomu Takeuchi, Masafumi Kawanishi, Megumi Nakanishi, Hironori Yamasaki & Yoshiya Tanaka. (2022) Phase II/III Results of a Trial of Anti–Tumor Necrosis Factor Multivalent NANOBODY Compound Ozoralizumab in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology 74:11, pages 1776-1785.
Crossref
Crossref
Xin Zhang, Chang Liu, Yuan Xie, Qianqian Hu, Yuanyuan Chen & Jiangwei Li. (2022) Identification and characterization of blocking nanobodies against human CD70. Acta Biochimica et Biophysica Sinica.
Crossref
Crossref
Xiaodan Hu, Xiao Zhang, Yuan Liu, Meijing Gao, Manman Lin, Yajing Xie, Qing Zhu, Chongxin Xu, Xianjin Liu, Dalene Vosloo & Ofentse Jacob Pooe. (2022)
Generation of Human Domain Antibody Fragments as Potential Insecticidal Agents against
Helicoverpa armigera
by Cadherin-Based Screening
. Journal of Agricultural and Food Chemistry 70:37, pages 11510-11519.
Crossref
Crossref
Keke Huang, Tianlei Ying & Yanling Wu. (2022) Single-Domain Antibodies as Therapeutics for Respiratory RNA Virus Infections. Viruses 14:6, pages 1162.
Crossref
Crossref
Alireza Shoari, Mehdi Tahmasebi, Farnaz Khodabakhsh, Reza Ahangari Cohan, Akbar Oghalaie & Mahdi Behdani. (2022) Angiogenic biomolecules specific nanobodies application in cancer imaging and therapy; review and updates. International Immunopharmacology 105, pages 108585.
Crossref
Crossref
Chenliang Zhang, Qiulin Tang, Hongwei Xia, Huanji Xu & Feng Bi. (2022) Identification and characterization of inhibitory nanobody against p38δ. Biochemical and Biophysical Research Communications 600, pages 60-66.
Crossref
Crossref
Martina Gilodi, Simonetta Lisi, Erika F. Dudás, Marco Fantini, Rita Puglisi, Alexandra Louka, Paolo Marcatili, Antonino Cattaneo & Annalisa Pastore. (2022) Selection and Modelling of a New Single-Domain Intrabody Against TDP-43. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Elmira Karami, Shamsi Naderi, Reyhaneh Roshan, Mahdi Behdani & Fatemeh Kazemi-Lomedasht. (2022) Targeted therapy of angiogenesis using anti-VEGFR2 and anti-NRP-1 nanobodies. Cancer Chemotherapy and Pharmacology 89:2, pages 165-172.
Crossref
Crossref
Yang Shen, Alessandro Luchetti, Giselle Fernandes, Won Do Heo & Alcino J. Silva. (2022) The emergence of molecular systems neuroscience. Molecular Brain 15:1.
Crossref
Crossref
Elmira Karami & Fatemeh Kazemi-Lomedasht. (2022) Biosensors: Types, features, and application in biomedicine. Asian Pacific Journal of Tropical Biomedicine 12:9, pages 367.
Crossref
Crossref
Gunnar Houen. 2022. Therapeutic Antibodies. Therapeutic Antibodies
1
25
.
Nadja Groysbeck, Mariel Donzeau, Audrey Stoessel, Anne-Marie Haeberle, Stéphane Ory, Danièle Spehner, Patrick Schultz, Ovidiu Ersen, Mounib Bahri, Dris Ihiawakrim & Guy Zuber. (2021) Gold labelling of a green fluorescent protein (GFP)-tag inside cells using recombinant nanobodies conjugated to 2.4 nm thiolate-coated gold nanoparticles. Nanoscale Advances 3:24, pages 6940-6948.
Crossref
Crossref
Lu Zhang, Lizhen Wang, Shuaishuai Cao, Huanhuan Lv, Jingjing Huang, Guixi Zhang, Kaissar Tabynov, Qin Zhao & En-Min Zhou. (2021) Nanobody Nb6 fused with porcine IgG Fc as the delivering tag to inhibit porcine reproductive and respiratory syndrome virus replication in porcine alveolar macrophages. Veterinary Research 52:1.
Crossref
Crossref
James N. Miller, Reinhard Niessner & Dietmar Knopp. 2000. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry
1
36
.
Tong Wu & Jianwei Zhu. (2021) Recent development and optimization of pseudomonas aeruginosa exotoxin immunotoxins in cancer therapeutic applications. International Immunopharmacology 96, pages 107759.
Crossref
Crossref
Yaozhong Hu, Sihao Wu, Yi Wang, Jing Lin, Ying Sun, Chuan Zhang, Jiaxin Gu, Feier Yang, Huan Lv, Xuemeng Ji, Yan Zhang, Serge Muyldermans & Shuo Wang. (2021) Unbiased Immunization Strategy Yielding Specific Nanobodies against Macadamia Allergen of Vicilin-like Protein for Immunoassay Development. Journal of Agricultural and Food Chemistry 69:17, pages 5178-5188.
Crossref
Crossref
Zhimin Xu, Chuangnan Qiu, Biyan Wen, Shuang Wang, Linfeng Zhu, Lin Zhao & Huangjin Li. (2021) A bispecific nanobody targeting the dimerization interface of epidermal growth factor receptor: Evidence for tumor suppressive actions in vitro and in vivo. Biochemical and Biophysical Research Communications 548, pages 78-83.
Crossref
Crossref
Abdullah O. Alamoudi. (2021) Radiomics, aptamers and nanobodies: New insights in cancer diagnostics and imaging. Human Antibodies 29:1, pages 1-15.
Crossref
Crossref
Anne-Marie Castonguay, Claude Gravel & Martin Lévesque. (2021) Treating Parkinson’s Disease with Antibodies: Previous Studies and Future Directions. Journal of Parkinson's Disease 11:1, pages 71-92.
Crossref
Crossref
Salma Bessalah, Samira Jebahi, Naceur Mejri, Imed Salhi, Touhami Khorchani & Mohamed Hammadi. (2021) Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19). 3 Biotech 11:2.
Crossref
Crossref
Zhen-Feng Li, Jie-Xian Dong, Natalia Vasylieva, Yong-Liang Cui, De-Bin Wan, Xiu-De Hua, Jing-Qian Huo, Dong-Chen Yang, Shirley J. Gee & Bruce D. Hammock. (2021) Highly specific nanobody against herbicide 2,4-dichlorophenoxyacetic acid for monitoring of its contamination in environmental water. Science of The Total Environment 753, pages 141950.
Crossref
Crossref
Reyhaneh Roshan, Shamsi Naderi, Mahdi Behdani, Reza Ahangari Cohan, Hajarsadat Ghaderi, Mohammad Ali Shokrgozar, Majid Golkar & Fatemeh Kazemi-Lomedasht. (2021) Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy. Molecular Immunology 129, pages 70-77.
Crossref
Crossref
Raid Saleem Al-Baradie. (2020) Nanobodies as versatile tools: A focus on targeted tumor therapy, tumor imaging and diagnostics. Human Antibodies 28:4, pages 259-272.
Crossref
Crossref
Pinpin Ji, Jiahong Zhu, Xiaoxuan Li, Wenqi Fan, Qianqian Liu, Kun Wang, Jiakai Zhao, Yani Sun, Baoyuan Liu, En-Min Zhou & Qin Zhao. (2020) Fenobody and RANbody-based sandwich enzyme-linked immunosorbent assay to detect Newcastle disease virus. Journal of Nanobiotechnology 18:1.
Crossref
Crossref
Shamsi Naderi, Reyhaneh Roshan, Hajarsadat Ghaderi, Mahdi Behdani, Sara Mahmoudi, Mahdi Habibi-Anbouhi, Mohammad Ali Shokrgozar & Fatemeh Kazemi-Lomedasht. (2020) Selection and characterization of specific nanobody against neuropilin-1 for inhibition of angiogenesis. Molecular Immunology 128, pages 56-63.
Crossref
Crossref
Masoud Farshbaf, Ahmad Yari Khosroushahi, Solmaz Mojarad-Jabali, Amir Zarebkohan, Hadi Valizadeh & Paul R. Walker. (2020) Cell surface GRP78: An emerging imaging marker and therapeutic target for cancer. Journal of Controlled Release 328, pages 932-941.
Crossref
Crossref
Qiushuang Zhang, Fei Ding, Xinlong Liu, Jian Shen, Yue Su, Jiwen Qian, Xinyuan Zhu & Chuan Zhang. (2020) Nanobody-guided targeted delivery of microRNA via nucleic acid nanogel to inhibit the tumor growth. Journal of Controlled Release 328, pages 425-434.
Crossref
Crossref
Ivan Peyron, Claire Kizlik‐Masson, Marie‐Daniéla Dubois, Sénadé Atsou, Stephen Ferrière, Cécile V. Denis, Peter J. Lenting, Caterina Casari & Olivier D. Christophe. (2020) Camelid‐derived single‐chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications. Research and Practice in Thrombosis and Haemostasis 4:7, pages 1087-1100.
Crossref
Crossref
Yanan Wang, Jinqing Jiang, Hanna Fotina, Haitang Zhang & Junjie Chen. (2020) Advances in Antibody Preparation Techniques for Immunoassays of Total Aflatoxin in Food. Molecules 25:18, pages 4113.
Crossref
Crossref
Qi Chen, Danyang Sun, Hua Pei, Benchao Su, Kunlu Bao, Hongmei Cao, Chenghui Zhang, Bruce D. Hammock & Xing Liu. (2020) Development of a nanobody tagged with streptavidin-binding peptide and its application in a Luminex fluoroimmunoassay for alpha fetal protein in serum. RSC Advances 10:40, pages 23767-23774.
Crossref
Crossref
Shufeng Li, Kunpeng Jiang, Ting Wang, Wei Zhang, Minke Shi, Baojun Chen & Zichun Hua. (2020) Nanobody against PDL1. Biotechnology Letters 42:5, pages 727-736.
Crossref
Crossref
Yixin He, Yarong Ren, Bing Guo, Yifei Yang, Yanwei Ji, Daohong Zhang, Jianlong Wang, Yanru Wang & Hong Wang. (2020) Development of a specific nanobody and its application in rapid and selective determination of Salmonella enteritidis in milk. Food Chemistry 310, pages 125942.
Crossref
Crossref
Yumin Teng, Joyce L. Young, Bryan Edwards, Philip Hayes, Lorraine Thompson, Colette Johnston, Carolyn Edwards, Yun Sanders, Michele Writer, Debora Pinto, Yanjing Zhang, Mila Roode, Peter Chovanec, Louise Matheson, Anne E. Corcoran, Almudena Fernandez, Lluis Montoliu, Beatrice Rossi, Valentina Tosato, Kresimir Gjuracic, Dmitri Nikitin, Carlo Bruschi, Brian McGuinness, Thomas Sandal & Mike Romanos. (2020) Diverse human VH antibody fragments with bio-therapeutic properties from the Crescendo Mouse. New Biotechnology 55, pages 65-76.
Crossref
Crossref
Natalia Kovalova, Jeffrey Boyles, Yi Wen, Derrick R. Witcher, Patricia L. Brown‐Augsburger, Victor J. Wroblewski & Lukasz K. Chlewicki. (2020) Validation of a de‐immunization strategy for monoclonal antibodies using cynomolgus macaque as a surrogate for human. Biopharmaceutics & Drug Disposition 41:3, pages 111-125.
Crossref
Crossref
James Melrose. (2020) Improvements in drug delivery and monitoring of diseases in biotherapeutics. Journal of Stem Cell Research & Therapeutics 6:1, pages 53-54.
Crossref
Crossref
Ruonan Feng, Ruixue Wang, Jessica Hong, Christopher M Dower, Brad St Croix & Mitchell Ho. (2020) Isolation of rabbit single domain antibodies to B7-H3 via protein immunization and phage display. Antibody Therapeutics 3:1, pages 10-17.
Crossref
Crossref
Elmira Karami, Mahdi Behdani & Fatemeh Kazemi-Lomedasht. (2020) Albumin nanoparticles as nanocarriers for drug delivery: Focusing on antibody and nanobody delivery and albumin-based drugs. Journal of Drug Delivery Science and Technology 55, pages 101471.
Crossref
Crossref
Yomna Badawi & Hiroshi Nishimune. (2020) Super-resolution microscopy for analyzing neuromuscular junctions and synapses. Neuroscience Letters 715, pages 134644.
Crossref
Crossref
Li Cao, Qiyu Li, Zhen Tong, Yutong Xing, Keyuan Xu, Jessica Yijia Wang, Wenjing Li, Jianhua Zhao, Liqing Zhao & Zhangyong Hong. (2020) HER2-specific immunotoxins constructed based on single-domain antibodies and the improved toxin PE24X7. International Journal of Pharmaceutics 574, pages 118939.
Crossref
Crossref
Noémie Pied & Harald Wodrich. (2019) Imaging the adenovirus infection cycle. FEBS Letters 593:24, pages 3419-3448.
Crossref
Crossref
A. R. Satvik Iyengar, Shreya Gupta, Snehal Jawalekar & Abhay H. Pande. (2019) Protein Chimerization: A New Frontier for Engineering Protein Therapeutics with Improved Pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics 370:3, pages 703-714.
Crossref
Crossref
Xinyu Gao, Alex Conard, Chunpeng Yang, Yancheng Zhan, Fang Zeng, Jian Shi, Wei Li, Dimiter S. Dimitrov & Rui Gong. (2019) Optimization of the C-Terminus of an Autonomous Human IgG1 CH2 Domain for Stability and Aggregation Resistance. Molecular Pharmaceutics 16:8, pages 3647-3656.
Crossref
Crossref
Tian Li, Yafeng Shen, Fangxing Lin, Wenyan Fu, Shuowu Liu, Chuqi Wang, Jizhou Liang, Xiaoyan Fan, Xuting Ye, Ying Tang, Min Ding, Yongji Yang, Changhai Lei & Shi Hu. (2019) Targeting RyR2 with a phosphorylation site–specific nanobody reverses dysfunction of failing cardiomyocytes in rats. The FASEB Journal 33:6, pages 7467-7478.
Crossref
Crossref